Aktis Oncology
(NASDAQ) AKTS
Aktis Oncology Financials at a Glance
Market Cap
$1.00B
Revenue (TTM)
$0.93
Net Income (TTM)
$12.06
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
4.77 (High)
Dividend
$0.00
Beta (Volatility)
4.77 (High)
Price
$18.61
Volume
540,744
Open
$17.82
Price
$18.61
Volume
540,744
Open
$17.82
Previous Close
$18.63
Daily Range
$17.19 - $18.87
52-Week Range
$0.04 - $29.16
Dividend
$0.00
Beta (Volatility)
4.77 (High)
Price
$18.61
Volume
540,744
Open
$17.82
Previous Close
$18.63
Daily Range
$17.19 - $18.87
52-Week Range
$0.04 - $29.16
AKTS News
AKTS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aktis Oncology
Industry
Biotechnology
Sector
Health CareCEO
Matthew Roden, PhD
Website
www.aktisoncology.comHeadquarters
Boston, MA 02210, US
AKTS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-35%
Net Income Margin
-30%
Return on Equity
0%
Return on Capital
-17%
Return on Assets
-13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.00B
Shares Outstanding
55.17M
Volume
540.74K
Short Interest
0.00%
Avg. Volume
401.82K
Financials (TTM)
Gross Profit
$1.49M
Operating Income
$52.05M
EBITDA
$50.48M
Operating Cash Flow
$14.76M
Capital Expenditure
$2.86M
Free Cash Flow
$11.90M
Cash & ST Invst.
$297.17M
Total Debt
$12.01M
Aktis Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$933.00K
N/A
Gross Profit
$933.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
$1.00B
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$12.06M
N/A
EBITDA
$15.19M
N/A
Quarterly Fundamentals
Net Cash
$234.36M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$10.50M
N/A
Short Term Debt
$1.37M
N/A
Return on Assets
-13.48%
N/A
Return on Invested Capital
-16.93%
N/A
Free Cash Flow
$15.03M
N/A
Operating Cash Flow
$12.80M
N/A